Skip to main content
. Author manuscript; available in PMC: 2017 Nov 22.
Published in final edited form as: J Steroid Biochem Mol Biol. 2017 Feb 14;168:91–101. doi: 10.1016/j.jsbmb.2017.02.008

Fig. 8.

Fig. 8

HSP70 activators and inhibitor show additive effects to inhibit cancer cell growth. LNCaP cancer cells were treated with DMSO, HMBA, 4a1, SW02, Pifitrin-μ or their combinations at the indicated concentrations for 72 h in four replicate experiments. The cell viability was evaluated with MTT assay. The results are a representative one of three independent experiments and the mean (±SD) is represented.